Source: Eur Respir J 2011; 37: 384
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Schuetz P., Suter-Widmer I., Chaudri A., Christ-Crain M., Zimmerli W., Mueller B.. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 2011; 37: 384

Member's Comments

No comment yet.

Related content which might interest you: Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Comparision of procalcitonin and CURB-65 in pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)? Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Role of procalcitonin (PCT) as a marker of severity of community acquired bacterial pneumonia (CABP) compared to PSI, CRB65 abd CURB65 Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Source: Eur Respir J 2008; 31: 356-362 Year: 2008 CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortality-rate settings Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Predicting severe sepsis in community-acquired pneumonia using CURB65 and PSI scores Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Performance of early warning score and CURB-65 in predicting severe outcome in community-acquired pneumonia Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia – A prospective study Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Physiological score SIPF (shock index and hypoxemia) is an accurate predictor of ICU admission in community-acquired pneumonia Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Predictive value of procalcitonin in ventilator-associated pneumonia Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Comparison of biomarkers and SOFA score prognostic value in ventilator-associated pneumonia Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Determinants of hospital costs in community-acquired pneumonia Source: Eur Respir J 2008; 31: 1061-1067 Year: 2008 The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Diagnostic and prognostic utility of procalcitonin (PCT) measurements in patients with hospitalized community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009